000504 *ST南华生物
2026/03 -
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资0--005,4165,484
投资性房地产0--0000
固定资产163,517-1.16%165,43513,49414,28220,362
在建工程1,3821,179.63%108000
无形资产55,550-0.47%55,8111,857441361
商誉6,2270.00%6,2271,9831,9838,441
其他非流动资产22,692-10.06%25,230188,93194,410102,481
249,368-1.36%252,811206,266116,531137,130

流动资产
货币资金183,374-47.12%346,768207,363493,811218,148
应收账款164,275-24.82%218,521139,582123,224158,759
存货48,538160.03%18,66634,05910,6604,501
其他流动资产370,869139.32%154,96620,90127,15534,828
767,0563.81%738,920401,904654,851416,236

流动负债
短期借款278,4083.02%270,254028,11763,083
应付票据0--0000
应付帐款14,395-2.18%14,71684,46682,21382,032
其他流动负债261,9630.68%260,185221,005342,068310,037
554,7651.76%545,155305,471452,397455,152
流动资产净值212,2919.56%193,76496,433202,454(38,916)
资产总额减流动负债461,6593.38%446,576302,699318,98698,215

非流动负债
长期借款52,9500.00%52,9509,00000
应付债券0--0000
其他非流动负债39,6369.74%36,11911,70114,31218,029
92,5863.95%89,06920,70114,31218,029

总权益
    实收股本330,0230.00%330,023330,023330,023311,574
    储备项目(53,171)-17.27%(64,272)(92,928)(73,082)(297,565)
股东权益276,8524.18%265,751237,095256,94114,009
非控股权益92,2200.51%91,75544,90347,73366,177